stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Current ratio
Integer Holdings Corporation's current ratio at the end of the quarter to 30 September 2026 was 4.0×, up 0.7× from fiscal 2025 (3.3×). Over the past ten years it has ranged from 2.3× (fiscal 2019) to 3.3× (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.3× | 12.34% |
| FY2024 | 3.0× | 5.68% |
| FY2023 | 2.8× | 12.03% |
| FY2022 | 2.5× | (12.07%) |
| FY2021 | 2.8× | 7.33% |
| FY2020 | 2.6× | 13.98% |
| FY2019 | 2.3× | (8.29%) |
| FY2018 | 2.5× | (0.62%) |
| FY2017 | 2.5× | (8.88%) |
| FY2016 | 2.8× | 3.94% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 4.0× | 6.73% |
| Jun 2026 | 3.7× | (0.57%) |
| Mar 2026 | 3.8× | 13.13% |
| Dec 2025 | 3.3× | (10.51%) |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| AXGN AxoGen, Inc. compare | 12.0× |
| TXG 10x Genomics compare | 5.7× |
| TMDX TransMedics Group, Inc. compare | 4.5× |
| ITGR Integer Holdings Corporation | 4.0× |
| NEOG Neogen Corporation compare | 3.9× |
| IRTC iRhythm Holdings, Inc. compare | 3.6× |
| UFPT UFP Technologies, Inc. compare | 3.0× |
| HAE Haemonetics Corporation compare | 2.8× |
| LIVN LivaNova PLC compare | 1.7× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement